LDL-cholesterol 2005 - Method comparison study between Friedewald's formula and direct Wako method: Design of study and basic conclusions;LDL-cholesterol 2005 - Porovnávacia štúdia stanovenia metódou Friedewaldovho vzorca a priamou metódou Wako: Dizajn štúdie a základné závery

Klinicka Biochemie a Metabolismus

Volumn 13, Issue 4, 2005, Pages 190-196

  Gaško, Rudolf ^a   De Cordova, C M M ^b   Klimova E ^c   Hefler, C M R ^f   Schoonjans, F ^d,e  

^a Zdravotná poist'Ov a   (Slovenia)

^b REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

^d GHENT UNIVERSITY   (Belgium)

^e MedCalc Software   (Belgium)

^f NONE

Author keywords

Direct Wako method; Friedewald's formula; LDL cholesterol; Method comparison study

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CALCULATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

EID: 30944436671     PISSN: 12107921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Amarenco, P., Lavallee, P., Touboul, P. J. Stroke prevention, blood cholesterol, and statins. Lancet Neurol., 2004, 3, p. 271-278.
2. Bayer, P., Veinber, F., Couderc, R. et al. Évaluation multicentrique de quatre méthodes de dosage direct du cholésterol-LDL Ann. Biol. Clin., 2005, 63, p. 27-41.
3. Broedl, U. C., Geiss, H. CH., Parhofer, K. Comparison of current guidelines for primary prevention of coronary heart disease. J. Gen. Intern. Med., 2003, 18, p. 190-196.
4. Collins, R., Armitage, J., Parish, S., Sleigh, P., Peto, R. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatinin 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 2003, 361, p. 2005-2016.
5. Collins, R., Armitage, J., Parish, S., Sleigh, P., Peto, R. Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet, 2004, 363, p. 757-767.
6. De Backer, G., Ambrosioni, E., Borch-Johnsen, K. et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis, 2004, 173, p. 381-391.
7. De Cordova, C. M. M., Schneider, C. R., Juttel, I. D., de Cordova, M. M. Comparison of LDL-cholesterol direct measurement with the estimate using the Friedewald formula in a sample of 10 664 patients. Arq. Brasil. Cardiol., 2004, 83, p. 482-487.
8. Franzini, C., Valente, C., Luraschi, P. Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B: relationships among the different measurements. Scand. J. Clin. Lab. Invest., 2004, 64, p. 703-708.
9. Friedewald, W. T., Levy, R. I., Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 1972, 18, p. 499-502.
10. Gaško, R. Koniec p-hodnoty v medicinskej štatistike - stále ešte nie, ale už na dohlad. Lab. Diagnostika, 2004, 9, s. 67-71.
11. Grundy, S. M., Cleeman, J. I., Merz, C. N. B. et al., for the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 2004;110, p. 227-239.
12. Klee, G. G. Clinical interpretation of reference intervals and reference limits. A plea for assay harmonization. Clin. Chem. Lab. Med., 2004, 42, p. 752-757.
13. Lindsey, C. C., Graham, M. R., Johnston, T. P., Kiroff, C. G., Freshley, A. A clinical comparison of calculated versus direct measurement of low-density lipoprotein cholesterol levels. Pharmacotherapy, 2004, 24, p. 167-172.
14. Linnet, K. Necessary sample size for method comparison studies based on regression analysis. Clin. Chem., 1999, 45, p. 882-894.
15. Lott, J. A., Mitchell, L. C., Moeschberger, M. L., Sutherland, D. E. Estimation of reference ranges: how many subject are needed? Clin. Chem., 1992, 38, p. 648-650.
16. Nauck, M., Warnick, G. R., Rifai, N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin. Chem., 2002, 48, p. 236-254.
17. Okada, M., Matsuto, T., Miida, T., Obayashi, K., Zhu, Y., Fueki, Y. Lipid analyses for the management of vascular diseases. J. Athero. Thromb., 2004, 11, p. 190-199.
18. Oosterhuis, W. P., Bruns, D. E., Watine, J., Sandberg, S., Horvath, A. R. Evidence-Based Guidelines in Laboratory Medicine: Principles and Methods. Clin. Chem., 2004, 50, p. 806-818.
19. Passing, H., Bablok, W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J. Clin. Chem. Clin. Biochem., 1983, 21, p. 709-720.
20. Passing, H., Bablok, W. Comparison of several regresion procedures for method comparison studies and determination of sample size. J. Clin. Chem. Biochem., 1984, 22, p. 431-445.
21. Pedrinelli, R., Esposti, E. D., Dell'Omo, G. LDL cholesterol and global risk stratification in referred hypertensive patients. Atherosclerosis, 2005, 180, p. 137-143.
22. Puavilai, W., Laoragpongse, D. Is calculated LDL-C by using the new modified Friedewald equation better than the standard Friedewald equation? J. Med. Assoc. Thai., 2004, 87, p. 589-593.
23. rd ed. London, New York, Washington D. C. Chapman and Hall/CRC Boca Raton 2004, 1193 pp.
24. Stejskal, D., Pastorková, R., Franková, M., Bartek, J., Horalik, D. Benefit přímého stanovení LDL-cholesterolu (srovnání měřní LDL s jeho odhadem pomocí výpočtu). Vnitř. Lék., 1998, 44, p. 707-713.
25. Taylor, A., Shaw, L. J., Fayad, Z. et al. Tracking atherosclerosis regression: a clinical tool in preventive cardiology. Review. Atherosclerosis, 2005, 180, p. 1-10.
26. Tremblay, A. J., Morrissette, H., Gagne, J. M., Bergeron, J., Gagne, C., Couture, P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin. Biochem., 2004, 37, p. 785-790.
27. Turkalp, I., Cil, Z., Ozkazanc, D. Analytical performance of a direct assay for LDL-cholesterol: a comparative assessment versus Friedewald's formula - original investigation. Anadolu. Kordiyol. Derg., 2005, 5, p. 13-17.
28. Wagner, A. M., Zapico, E., Boner, R., Perez, A., Ordonez-Llanos, J. The effect of VLDL particles on the accuracy of a direct LDL-cholesterol method in type 2 diabetic patients. Clin. Biochem., 2003, 36, p. 177-183.
29. Warnick, G. R., Myers, G. L., Cooper, G. R., Rifai, N. Impact of the third cholesterol report from the Adult Treatment Panel of the National cholesterol Education Program on the clinical laboratory. Clin. Chem., 2002, 48, p. 11-17.
30. Westgard, J. O. Method validation - the comparison of methods experiment. Lesson 2000. www.wetgard.com
31. MedCalc for Windows. Software manual, version 8, 2005, 152 pp. MedCalc Software, Mariakerke, Belgium, www.medcalc.be
32. National cholesterol education program expert panel. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA, 2001, 285, p. 2486-2497.
33. NCCLS EP9-A. Method comparison and bias estimation using patients samples. National Committee for Clinical Laboratory Standards, Wayne, PA, 1995.
34. Odporúčania pre diagnostiku a liečbu dyslipoproteínémií dospelych. Lipidový konsenzus - 2. Cardiol., 2002, 11, s. 47-55.
35. Odporúčania pre optimálnu diagnostiku a liečbu dyslipoproteínémií u dospelých. "Lipidovy konsenzus - 2." Interná medicína, 2003, 3, s. 10-18.